Zentalis Pharmaceuticals, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ANNX
|
Annexon, Inc. | $7.25 | $523.15 M | -3.93 | 71 | $0 |
 BPMC
|
Blueprint Medicines Corporation | $97.56 | $6.47 B | -21.48 | 638 | $249.38 M |
 CGEM
|
Cullinan Oncology, Inc. | $15.98 | $1.29 B | -7.16 | 85 | $0 |
 DAWN
|
Day One Biopharmaceuticals, Inc. | $15.14 | $1.12 B | -5.11 | 174 | $0 |
 DSGN
|
Design Therapeutics, Inc. | $5.55 | $217.51 M | -3.7 | 57 | $0 |
 ERAS
|
Erasca, Inc. | $2.95 | $647.94 M | -2.83 | 126 | $0 |
 GLUE
|
Monte Rosa Therapeutics, Inc. | $9.36 | $243.38 M | -1.59 | 129 | $0 |
 GRCL
|
Gracell Biotechnologies Inc. | $10.25 | $989.87 M | -10.57 | 314 | $0 |
 ICVX
|
Icosavax, Inc. | $15.31 | $769.04 M | -6.96 | 60 | $582,000 |
 INZY
|
Inozyme Pharma, Inc. | $4.06 | $286.39 M | -3.43 | 59 | $0 |
|
ITOS
|
iTeos Therapeutics, Inc. | $9.22 | $603.25 M | -4.42 | 157 | $12.60 M |
 KYMR
|
Kymera Therapeutics, Inc. | $47.66 | $2.02 B | -13.13 | 184 | $78.59 M |
 LIFE
|
aTyr Pharma, Inc. | $1.90 | $131.12 M | -2.16 | 56 | $353,000 |
|
MRTX
|
Mirati Therapeutics, Inc. | $58.70 | $4.12 B | -4.82 | 587 | $12.44 M |
 OLMA
|
Olema Pharmaceuticals, Inc. | $12.06 | $734.41 M | -6.56 | 80 | $0 |
|
PTGX
|
Protagonist Therapeutics, Inc. | $45.96 | $2.04 B | 13.7 | 125 | $60.00 M |
 RVMD
|
Revolution Medicines, Inc. | $56.75 | $6.66 B | -10.51 | 443 | $11.58 M |
 SANA
|
Sana Biotechnology, Inc. | $3.39 | $1.55 B | -4.59 | 328 | $0 |
 SNDX
|
Syndax Pharmaceuticals, Inc. | $19.73 | $1.66 B | -6.02 | 184 | $0 |
 THRX
|
Theseus Pharmaceuticals, Inc. | $4.07 | $181.50 M | -3.03 | 38 | $0 |
 VECT
|
VectivBio Holding AG | $16.87 | $1.06 B | -8.03 | 0 | $27.34 M |